Maiwald Magazine

Press Coverage

5 Dec 2025 - Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma and Denali have entered into a $275 million financing agreement which, pursuant to a synthetic royalty agreement, is based on future net sales of tividenofusp alfa. Tividenofusp alfa is Denali’s lead investigational TransportVehicle™-enabled enzyme rep...

25 Aug 2025 - Press Coverage

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfront payment of $885 million. The agreement allows BeOne to sell additional royalty rights in Imdelltr...

14 Jul 2025 - Press Coverage

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Maiwald in the press

Publications

29 Apr 2026 - Publication

Mobile foot measurement’s IP battle highlights easily overlooked step in startup journey, Managing IP, 2026

In an article for Managing IP, Dr Christian Meyer of Maiwald, in collaboration with Footprint Technologies, explains how a single process patent has had a significant impact o...

28 Apr 2026 - Publication

Preliminary Injunctions in German Pharmaceutical Patent Litigation, Newsletter of the AIPLA Chemical Practice Committee, Spring 2026, Volume 14, Issue 1

In his article “Preliminary Injunctions in German Pharmaceutical Patent Litigation”, published in the Newsletter of the AIPLA Chemical Practice Committee, Spring 2026, Vol...

22 Apr 2026 - Publication

The »Malta issue« of unitary patents

All publications

Events

Tue.

19 May 2026 |Upcoming

Maiwald at C5’s 19th Annual Pharma & Biotech Patent Litigation Forum in Europe

Maiwald will take part in C5’s 19th Annual Forum on Pharma & Biotech Patent Litigation in Europe, which will be held on 19–20 May 2026 at the Radisson Blu Hotel Amsterdam City Center. We are pleased that our colleague Dr. Ulrike Herr will be attending on site.

Tue.

2 Jun 2026 |Upcoming

Joint symposium with Oblon in Tokyo | 2 June 2026

Oblon and Maiwald are pleased to invite you to a complimentary joint international symposium on: U.S. and European patent practice: Important Aspects for Practitioners. Date and venue: Tuesday, 2 June 2026, 13:00 JST, at the AP Marunouchi, Tokyo

Fri.

8 May 2026 |Past Event

STARTUP CAMP 2026 in Heutal

From 8 to 10 May 2026, founders, experts and creative minds will gather in Heutal, Austria, for the cross-border STARTUP CAMP 2026. The event is designed to help early-stage companies and aspiring founders develop their business ideas and connect with experienced professionals from various disciplines. On Saturday, 9 May...

Sat.

2 May 2026 |Past Event

Maiwald at INTA Annual Meeting in London | 2-6 May 2026

Maiwald will once again participate in the INTA Annual Meeting, taking place in London from 2–6 May 2026 at ExCeL London. We are pleased that Susanne Ferstl, Rafal Drozdz and Alexander Müller

All events

News and Releases

Maiwald Blog

Analysis of Examination Standards and Case Law for AI and Software-Related Inventions

New fee schedule for the Unified Patent Court (UPC) from 1 January 2026

Why Patent Defense and Military Technologies?

Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Staff News

Maiwald appoints Dr. Kerstin Wolff as Partner

Maiwald appoints Martina Boidol, Dr. Anja Fux, and Sebastian Herzog as managing partners

Dr Iris Müller and Dr Gabriel Kiefl sworn in as German patent attorneys

Publications

Mobile foot measurement’s IP battle highlights easily overlooked step in startup journey, Managing IP, 2026

Preliminary Injunctions in German Pharmaceutical Patent Litigation, Newsletter of the AIPLA Chemical Practice Committee, Spring 2026, Volume 14, Issue 1

The »Malta issue« of unitary patents

Awards

Managing IP EMEA Awards 2026

The Legal 500 EMEA 2026: Maiwald recommended in three practice areas

Maiwald recognized by FOCUS as a Top Medium-Sized Employer 2026

Events

Maiwald at C5’s 19th Annual Pharma & Biotech Patent Litigation Forum in Europe

Joint symposium with Oblon in Tokyo | 2 June 2026

STARTUP CAMP 2026 in Heutal

Maiwald at INTA Annual Meeting in London | 2-6 May 2026